Seven Bridges
2009
FOUNDED
PRIVATE
STATUS
201-300
EMPLOYEES
Series B
LATEST DEAL TYPE
4
INVESTORS
Description
Developer of a biomedical data analysis platform intended to accelerate scientific discovery. The company's platform delivers end-to-end bioinformatic data analytics including access to datasets, analytic workflows and algorithms, cloud-computing infrastructure and scientific support that speeds the path from raw experimental data to new treatments and diagnostics, enabling companies to accelerate scientific discovery with fast, secure and collaborative genomic and healthcare data analytics.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Enterprise Systems (Healthcare)
Primary Office
- 529 Main Street
- Suite 6610
- Boston, MA 02129
- United States
+1 (617) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Seven Bridges’s full profile, request a free trial.
Seven Bridges Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B) | 01-Apr-2018 | 0000 | Completed | Generating Revenue | ||
| 5. Secondary Transaction - Private | 0000 | Completed | Generating Revenue | |||
| 4. Grant | 07-Nov-2017 | 0000 | Completed | Generating Revenue | ||
| 3. Later Stage VC (Series A) | 16-Feb-2016 | 0000 | 0000 | 00000 | Completed | Generating Revenue |
| 2. Grant | 11-Mar-2015 | $2.99M | Completed | Generating Revenue | ||
| 1. Debt - General | Completed | Startup |
Seven Bridges Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | 000,000 | 00.000000 | 0000.0 | 0000.0 | 00 | 0000.0 | 00.000 | |
| Series A | 00,000 | 00.000000 | 0000 | 0000 | 00 | 0000 | 0.000 |
Seven Bridges Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| WuXi NextCODE | Venture Capital-Backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
| 00000000 | Venture Capital-Backed | Mountain View, CA | 00 | 00000 | 0000000000 0 | 00000 |
Seven Bridges Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000000 | 04-Apr-2017 | 000000000 | Biotechnology | 000000 00000-000000000 00.0 |
Seven Bridges Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 0000000000 | 04-Apr-2017 | 000000000 | Completed |
|
Seven Bridges Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | |||
| Kryssen Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Genomics England | SBIC | 000 0000 | 000000 0 | |||
| U.K. Department of Health & Social Care | Government | 000 0000 | 000000 0 |
Seven Bridges Executive Team (30)
11 Former Executives
You’re viewing 5 of 30 executives. Get the full list »Seven Bridges Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| James Sietstra | Self | President and Board Member | 000 0000 |
1 Former Board Member
You’re viewing 1 of 2 board members. Get the full list »